A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Lonza Group (OTCMKTS:LZAGY) Sees Strong Trading Volume - Time to Buy? - MarketBeat
Lonza Group (OTCMKTS:LZAGY) Sees Strong Trading Volume - Time to Buy? - MarketBeat
Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key P - PharmiWeb.com
Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key P - PharmiWeb.com
Will Lonza Group AG (Common Stock) (LO31) stock issue positive guidance - 2025 Price Targets & Risk Controlled Daily Plans - Newser
Will Lonza Group AG (Common Stock) (LO31) stock issue positive guidance - 2025 Price Targets & Risk Controlled Daily Plans - Newser
What MACD trends signal for Lonza Group AG (Common Stock) (LO3A) stock - Newser
What MACD trends signal for Lonza Group AG (Common Stock) (LO3A) stock - Newser
Microsize, Schedio link to buy Lonza’s Swiss micronization plant - Fierce Pharma
Microsize, Schedio link to buy Lonza’s Swiss micronization plant - Fierce Pharma
We Think Lonza Group (VTX:LONN) Is Taking Some Risk With Its Debt - simplywall.st
We Think Lonza Group (VTX:LONN) Is Taking Some Risk With Its Debt - simplywall.st
Why Lonza Group AG (LO3) stock is a must watch ticker - Market Growth Report & Capital Efficient Trade Techniques - moha.gov.vn
Why Lonza Group AG (LO3) stock is a must watch ticker - Market Growth Report & Capital Efficient Trade Techniques - moha.gov.vn
Innovation in action: Inside the technologies transforming bioavailability - nutritioninsight.com
Innovation in action: Inside the technologies transforming bioavailability - nutritioninsight.com
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com Australia
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com Australia
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook By Investing.com - Investing.com South Africa
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook By Investing.com - Investing.com South Africa
Morgan Stanley Upgrades Lonza Group to Overweight, Lifts PT - MarketScreener
Morgan Stanley Upgrades Lonza Group to Overweight, Lifts PT - MarketScreener
Morgan Stanley upgrades Lonza, citing valuation support ahead of 2026 guide - Investing.com
Morgan Stanley upgrades Lonza, citing valuation support ahead of 2026 guide - Investing.com
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com Nigeria
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com Nigeria
Switzerland: Microsize and Schedio Group to acquire Lonza’s Micro-Macinazione site in Switzerland - Investors in Healthcare
Switzerland: Microsize and Schedio Group to acquire Lonza’s Micro-Macinazione site in Switzerland Investors in Healthcare
Lonza Group Ltd: Strong Growth Prospects and Attractive Valuation Support Buy Rating - TipRanks
Lonza Group Ltd: Strong Growth Prospects and Attractive Valuation Support Buy Rating TipRanks
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com India
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook Investing.com India
Microsize und Schedio Group übernehmen Lonzas Standort Micro-Macinazione in der Schweiz - Bakersfield.com
Microsize und Schedio Group übernehmen Lonzas Standort Micro-Macinazione in der Schweiz Bakersfield.com
Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland - Business Wire
Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland - Business Wire
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page